Phase Ib study of drozitumab combined with cetuximab (CET) plus irinotecan (IRI) or with FOLFIRI ± bevacizumab (BV) in previously treated patients (Pts) with metastatic colorectal cancer (mCRC)

Autor:	A. D. Baron, C. L. O'Bryant, Y. Choi, A. Ashkenazi, S. Royer-Joo, C. C. Portera
Rok vydání:	2011
Předmět:	Cancer Research Oncology
Zdroj:	Journal of Clinical Oncology. 29:3581-3581
ISSN:	1527-7755 0732-183X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f83b9ca3e6a5b60d4b04ef99085a12cb https://doi.org/10.1200/jco.2011.29.15_suppl.3581 Zobrazit plný text záznamu